Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The purpose of this study was to describe the psychiatric treatment received by a well-defined sample of patients with borderline personality disorder and Axis II comparison subjects over 6 years of prospective follow-up. METHOD: 362 inpatients were interviewed about their treatment histories during their index admission (1992-1995). 290 patients met both Revised Diagnostic Interview for Borderlines and DSM-III-R criteria for borderline personality disorder and 72 met DSM-III-R criteria for at least 1 nonborderline Axis II disorder (and neither criteria set for borderline personality disorder). Over 94% of surviving patients were re-interviewed about their psychiatric treatment histories 2, 4, and 6 years later. RESULTS: Only 33% of borderline patients were hospitalized during the final 2 years of the 6-year follow-up, a substantial decline from the 79% who had prior hospitalizations at baseline. Much the same pattern emerged for day and/or residential treatment (from 55% to 22%). In contrast, about three quarters of borderline patients were still in psychotherapy and taking psychotropic medications after 6 years of follow-up. Additionally, over 70% of borderline patients participating in these outpatient modalities did so for at least 75% of each follow-up period. While rates of intensive psychotherapy declined significantly over time (from 36% to 16%), rates of intensive polypharmacy remained relatively stable over time, with about 40% of borderline patients taking 3 or more concurrent standing medications during each follow-up period, about 20% taking 4 or more, and about 10% taking 5 or more. CONCLUSIONS: The results of this study suggest that the majority of borderline patients continue to use outpatient treatment in a sustained manner through 6 years of follow-up, but only a declining minority use more restrictive and costly forms of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies on individuals with PD diagnoses demonstrated that BPD individuals differ in usage of outpatient, inpatient, and psychopharmacologic treatments when compared to other PD groups [7,8]”
Citations
Cited by
Linehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., Korslund, K. E., Tutek, D. A., Reynolds, S. K., & Lindenboim, N. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.757 · Cited by 2,025
“Patients with BPD use more services than those with major depression(13) and other personality disorders.(14) Among patients with BPD seen for treatment, 72% have had at least 1 psychiatric hospitalization and 97% have received outpatient treatment from a mean of 6.”
BackgroundBorderline personality disorder
Lieb, K., Zanarini, M. C., Schmahl, C., Linehan, M. M., & Bohus, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16770-6 · Cited by 1,369
Self-citationEvaluating three treatments for borderline personality disorder: a multiwave study
Clarkin, J. F., Levy, K. N., Lenzenweger, M. F., & Kernberg, O. F. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.922 · Cited by 997
“This chronic and debilitating syndrome is associated with high rates of medical and psychiatric utilization of services (6, 7).”
BackgroundPsychological therapies for people with borderline personality disorder.
Stoffers-Winterling, J. M., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005652.pub2 · Cited by 895
Cristea, I. A., Gentili, C., Cotet, C. D., Palomba, D., Barbui, C., & Cuijpers, P. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.4287 · Cited by 655
Zanarini, M. C., Frankenburg, F. R., Hennen, J., Reich, D. B., & Silk, K. R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2108 · Cited by 525
Self-citationBamelis, L. L. M., Evers, S. M. A. A., Spinhoven, P., & Arntz, A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12040518 · Cited by 497
Borderline personality disorder
Gunderson, J. G., Herpertz, S. C., Skodol, A. E., Torgersen, S., & Zanarini, M. C. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.29 · Cited by 470
Self-citationPsychological therapies for people with borderline personality disorder
Storebø, O. J., Stoffers-Winterling, J. M., Völlm, B. A., Kongerslev, M. T., Mattivi, J. T., Jørgensen, M. S., Faltinsen, E., Todorovac, A., Sales, C. P., Callesen, H. E., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012955.pub2 · Cited by 450
Prediction of the 10-Year Course of Borderline Personality Disorder
Zanarini, M. C., Frankenburg, F. R., Hennen, J., Reich, D. B., & Silk, K. R. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.827 · Cited by 447
Self-citationThe Medical Management of Depression
Mann, J. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050730 · Cited by 421
Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials
Lieb, K., Völlm, B., Rücker, G., Timmer, A., & Stoffers, J. M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.062984 · Cited by 410
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
The Subsyndromal Phenomenology of Borderline Personality Disorder: A 10-Year Follow-Up Study
Zanarini, M. C., Frankenburg, F. R., Reich, D. B., Silk, K. R., Hudson, J. I., & McSweeney, L. B. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.929 · Cited by 382
Self-citationBorderline personality disorder and childhood trauma: Evidence for a causal relationship
Ball, J. S., & Links, P. S. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0010-4 · Cited by 320
Pharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302
The cost of borderline personality disorder: societal cost of illness in BPD-patients
van Asselt, A. D. I., Dirksen, C. D., Arntz, A., & Severens, J. L. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2007.04.001 · Cited by 277
“Several studies [4,44] have found that BPD-patients continuously use outpatient treatment and”
BackgroundBorderline personality disorder and emotional responding: a review of the research literature
Rosenthal, M. Z., Gratz, K. L., Kosson, D. S., Cheavens, J. S., Lejuez, C. W., & Lynch, T. R. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.04.001 · Cited by 245
Zanarini, M. C., Frankenburg, F. R., Reich, D. B., Fitzmaurice, G., Weinberg, I., & Gunderson, J. G. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01155.x · Cited by 227
Self-citationZanarini, M. C., Frankenburg, F. R., Reich, D. B., & Fitzmaurice, G. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01543.x · Cited by 210
Self-citationEbner-Priemer, U. W., Welch, S. S., Grossman, P., Reisch, T., Linehan, M. M., & Bohus, M. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.04.014 · Cited by 207
“First, BPD patients without medication, who are often recruited for psychophysiological studies, are extremely rare (Zanarini et al., 2004) and may represent a healthier subgroup of BPD patients than medicated individuals.”
BackgroundBorderline Personality Disorder
Gunderson, J. G. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1007358 · Cited by 185
Paton, C., Crawford, M. J., Bhatti, S. F., Patel, M. X., & Barnes, T. R. E. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09228 · Cited by 177
“Gender Female 663 (63) 870 (56) Male 391 (37) 676 (44) Ethnicity White/white British 926 (88) 1,355 (88) Black/black British 26 (3) 55 (4) Asian 16 (2) 41 (3) Mixed or other 22 (2) 24 (2) Unspecified/unknown 64 (6) 71 (5) Age, y 16–25 173 (16) 229 (15) 26–35 268 (25) 383 (25) 36–45 294 (28) 455 (29) 46–55 220 (21) 344…”
BackgroundZanarini, M. C., Horwood, J., Wolke, D., Waylen, A., Fitzmaurice, G., & Grant, B. F. (2011) · Journal of Personality Disorders · doi:10.1521/pedi.2011.25.5.607 · Cited by 173
Self-citationvan Zutphen, L., Siep, N., Jacob, G. A., Goebel, R., & Arntz, A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.001 · Cited by 165
“About 5% of the BPD patients are regularly taking psychotropic med- cation, and these rates remain relatively stable after six years ollow-up (Zanarini et al., 2004).”
BackgroundZanarini, M. C., Frankenburg, F. R., Hennen, J., Reich, D. B., & Silk, K. R. (2005) · Journal of Personality Disorders · doi:10.1521/pedi.19.1.19.62178 · Cited by 161
Self-citationMcCloskey, M. S., New, A. S., Siever, L. J., Goodman, M., Koenigsberg, H. W., Flory, J. D., & Coccaro, E. F. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.01.002 · Cited by 157
“Roughly threequarters of all BPD patients report engaging in suicidal behavior at some point (Paris et al., 2004; Paris and Zweig-Frank, 2001; Zanarini et al., 2004) with up to 10% eventually committing suicide (Lieb et al., 2004).”
BackgroundBorderline Personality Disorder in Young People: Are We There Yet?
Chanen, A. M. (2015) · Journal of Clinical Psychology · doi:10.1002/jclp.22205 · Cited by 148
“…for the similarly sized psychosocial intervention literature, prescribing rates for BPD are paradoxically high (78% of patients for more than 75% of the time over a 6-year period) and polypharmacy occurs in 37% of patients (Zanarini et al., 2004), perhaps reflecting clinical needs and pressures.”
BackgroundBrief Reports: Prospective Assessment of Treatment Use by Patients With Personality Disorders
Bender, D. S., Skodol, A. E., Pagano, M. E., Dyck, I. R., Grilo, C. M., Shea, M. T., Sanislow, C. A., Zanarini, M. C., Yen, S., McGlashan, T. H., et al. (2006) · Psychiatric Services · doi:10.1176/appi.ps.57.2.254 · Cited by 143
Self-citationAnsell, E. B., Sanislow, C. A., McGlashan, T. H., & Grilo, C. M. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2007.02.001 · Cited by 143
Borderline personality disorder: a dysregulation of the endogenous opioid system?
Bandelow, B., Schmahl, C., Falkai, P., & Wedekind, D. (2010) · Psychological Review · doi:10.1037/a0018095 · Cited by 135
An 11-item measure to assess borderline traits in adolescents: Refinement of the BPFSC using IRT.
Sharp, C., Steinberg, L., Temple, J., & Newlin, E. (2014) · Personality Disorders: Theory, Research, and Treatment · doi:10.1037/per0000057 · Cited by 135
Hastrup, L. H., Jennum, P., Ibsen, R., Kjellberg, J., & Simonsen, E. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13094 · Cited by 133
“Even though medication is not specifically indicated for treatment of BPD, polypharmacy is common in BPD (67).”
BackgroundZanarini, M. C., Frankenburg, F. R., Vujanovic, A. A., Hennen, J., Reich, D. B., & Silk, K. R. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00362.x · Cited by 130
Self-citationCurrent and Possible Future Therapeutic Options for Huntington’s Disease
Ferguson, M. W., Kennedy, C. J., Palpagama, T. H., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221092517 · Cited by 148
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants
Ghaemi, S. N., Hsu, D. J., Thase, M. E., Wisniewski, S. R., Nierenberg, A. A., Miyahara, S., & Sachs, G. (2006) · Psychiatric Services · doi:10.1176/appi.ps.57.5.660 · Cited by 121
Hörz, S., Zanarini, M. C., Frankenburg, F. R., Reich, D. B., & Fitzmaurice, G. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.6.612 · Cited by 118
“These findings too are consistent with and extend the findings of our six-year follow-up study of this sample [1].”
InfluentialSelf-citationDefense Mechanisms in Schizotypal, Borderline, Antisocial, and Narcissistic Personality Disorders
Perry, J. C., Presniak, M. D., & Olson, T. R. (2013) · Psychiatry: Interpersonal and Biological Processes · doi:10.1521/psyc.2013.76.1.32 · Cited by 117
Intracellular pathways underlying the effects of lithium
Pasquali, L., Busceti, C. L., Fulceri, F., Paparelli, A., & Fornai, F. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833da5da · Cited by 112
Pharmacological interventions for people with borderline personality disorder
Stoffers-Winterling, J. M., Storebø, O. J., Pereira Ribeiro, J., Kongerslev, M. T., Völlm, B. A., Mattivi, J. T., Faltinsen, E., Todorovac, A., Jørgensen, M. S., Callesen, H. E., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012956.pub2 · Cited by 108
Keuroghlian, A. S., Frankenburg, F. R., & Zanarini, M. C. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.06.012 · Cited by 133
“Additionally, poor health-related self-care behaviors may perpetuate or amplify borderline personality symptomatology (Zanarini et al., 2004a) and interfere with vocational functioning, thereby decreasing the likelihood that borderline patients will recover.”
BackgroundInfluentialSelf-citationÁlvarez, I., Rodríguez, J. R., Guilera, G., & Bados, A. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.10.010 · Cited by 137
“The CLPS and MSAD studies reported similar percentages of subjects in BPD samples who participated in individual therapy during the early years of follow-up, which tended to decrease over time (range, 85%-64% and 96%-75%, respectively) [53,54].”
ResultBloom, J. M., Woodward, E. N., Susmaras, T., & Pantalone, D. W. (2012) · Psychiatric Services · doi:10.1176/appi.ps.201100311 · Cited by 103
Interactions of Borderline Personality Disorder and Anxiety Disorders Over 10 Years
Keuroghlian, A. S., Gunderson, J. G., Pagano, M. E., Markowitz, J. C., Ansell, E. B., Shea, M. T., Morey, L. C., Sanislow, C., Grilo, C. M., Stout, R. L., et al. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09748 · Cited by 88
Self-citationZanarini, M. C., Jacoby, R. J., Frankenburg, F. R., Reich, D. B., & Fitzmaurice, G. (2009) · Journal of Personality Disorders · doi:10.1521/pedi.2009.23.4.346 · Cited by 85
Self-citationPsychopharmacology of topiramate: from epilepsy to bipolar disorder
Cavanna, A. E., Monaco, F., Mula, M., Robertson, M. M., & Critchley, H. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2006.2.4.475 · Cited by 95
James, L. M., & Taylor, J. (2008) · British Journal of Clinical Psychology · doi:10.1348/014466508x299691 · Cited by 85
Kvarstein, E. H., Pedersen, G., Urnes, Ø., Hummelen, B., Wilberg, T., & Karterud, S. (2015) · Psychology and Psychotherapy: Theory, Research and Practice · doi:10.1111/papt.12036 · Cited by 83
McMain, S. F., Chapman, A. L., Kuo, J. R., Guimond, T., Streiner, D. L., Dixon-Gordon, K. L., Isaranuwatchai, W., & Hoch, J. S. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1802-z · Cited by 82
“Notably, individuals with BPD are overrepresented in primary care [9] and mental health care settings [10, 11].”
BackgroundChoi-Kain, L. W., Zanarini, M. C., Frankenburg, F. R., Fitzmaurice, G. M., & Reich, D. B. (2010) · Journal of Personality Disorders · doi:10.1521/pedi.2010.24.3.365 · Cited by 79
Self-citationZanarini, M. C., Reichman, C. A., Frankenburg, F. R., Reich, D. B., & Fitzmaurice, G. (2010) · International Journal of Eating Disorders · doi:10.1002/eat.20689 · Cited by 79
Self-citationZanarini, M. C., Temes, C. M., Frankenburg, F. R., Reich, D. B., & Fitzmaurice, G. M. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.01.034 · Cited by 78
“These interviews were: 1) the Background Information Schedule (Zanarini, 1992), 2) the Structured Clinical Interview for DSM-III-R Axis I Disorders (Spitzer et al., 1992), 3) the Revised Diagnostic Interview for Borderlines (Zanarini et al., 1989a), and 4) the Diagnostic Interview for DSM-III-R Personality Disorders (…”
BackgroundMethodInfluentialSelf-citationZanarini, M. C., Frankenburg, F. R., Reich, D. B., Conkey, L. C., & Fitzmaurice, G. M. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400055 · Cited by 77
“In a six-year prospective study, Zanarini and colleagues (7) found that patients with borderline personality disorder who had been hospitalized at the start of the study reported here—the McLean Study of Adult Development—were significantly more likely than those with other axis II disorders to have participated in 11…”
BackgroundResultInfluentialSelf-citationPalmer, S., Davidson, K., Tyrer, P., Gumley, A., Tata, P., Norrie, J., Murray, H., & Seivewright, H. (2006) · Journal of Personality Disorders · doi:10.1521/pedi.2006.20.5.466 · Cited by 74
Zimmerman, M., Martinez, J. H., Morgan, T. A., Young, D., Chelminski, I., & Dalrymple, K. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08428 · Cited by 71
Hallquist, M. N., Hipwell, A. E., & Stepp, S. D. (2015) · Journal of Abnormal Psychology · doi:10.1037/abn0000058 · Cited by 85
Long-Term Course of Borderline Personality Disorder: A Prospective 10-Year Follow-Up Study
Alvarez-Tomás, I., Soler, J., Bados, A., Martín-Blanco, A., Elices, M., Carmona, C., Bauzà, J., & Pascual, J. C. (2017) · Journal of Personality Disorders · doi:10.1521/pedi_2016_30_269 · Cited by 68
Zanarini, M. C., Frankenburg, F. R., Jager‐Hyman, S., Reich, D. B., & Fitzmaurice, G. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01247.x · Cited by 68
Self-citationZeifman, R. J., & Wagner, A. C. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.001 · Cited by 67
Davidson, K., Tyrer, P., Gumley, A., Tata, P., Norrie, J., Palmer, S., Millar, H., Drummond, L., Seivewright, H., Murray, H., et al. (2006) · Journal of Personality Disorders · doi:10.1521/pedi.2006.20.5.431 · Cited by 67
Fiorillo, A., Dell'Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Del Vecchio, V., Di Nicola, M., Ferrari, S., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s83130 · Cited by 67
Emotional sensitivity in youth with borderline personality pathology
Jovev, M., Chanen, A. M., Green, M. J., Cotton, S., Proffitt, T., Coltheart, M., & Jackson, H. J. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.019 · Cited by 83
“…of chronic BPD, as well as factors associated with the duration of illness, such as recurrent co-occuring Axis I disorders including substance use (Zanarini et al., 2004a), deliberate self-harm, cumulative traumatic events (Zanarini et al., 2005) and treatment (including polypharmacy) (Zanarini…”
BackgroundZanarini, M. C., Frankenbur, F. R., Weingeroff, J. L., Reich, D. B., Fitzmaurice, G. M., & Weiss, R. D. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03176.x · Cited by 64
Self-citationUpdate on pharmacotherapy of borderline personality disorder
Zanarini, M. C. (2004) · Current Psychiatry Reports · doi:10.1007/s11920-004-0041-9 · Cited by 70
Self-citationGunderson, J. G. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15070885 · Cited by 66
Zanarini, M. C., Frankenburg, F. R., Reich, D. B., Harned, A. L., & Fitzmaurice, G. M. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000232 · Cited by 72
“The follow-up interrater reliability (within 1 generation of follow-up raters) and follow-up longitudinal reliability (from 1 generation of raters to the next) of these 4 interviews have also been found to be good to excellent.(7,13,14) Most of our 2-year follow-up interviews were conducted within several months of th…”
BackgroundResultSelf-citationFarah, M. J., & Gillihan, S. J. (2012) · AJOB Neuroscience · doi:10.1080/21507740.2012.713072 · Cited by 68
Comtois, K. A., & Carmel, A. (2014) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-014-9416-9 · Cited by 77
“7% among non-high utilizers of inpatient psychiatric services, on the low end of previous prevalence estimates in outpatient care based on research diagnosis.(1,2) By contrast, 4.”
BackgroundPersonality disorders and medical comorbidity
Frankenburg, F. R., & Zanarini, M. C. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000228766.33356.44 · Cited by 70
Self-citationBorderline personality disorder and depressive disorder
Rao, S., & Broadbear, J. (2019) · Australasian Psychiatry · doi:10.1177/1039856219878643 · Cited by 45
Borderline Personality Disorder in the Primary Care Setting
Dubovsky, A. N., & Kiefer, M. M. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.005 · Cited by 63
Doering, S. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000724 · Cited by 55
“Empirically Validated Treatments Treatment guidelines from the United States (109), the United Kingdom (110), and Germany (111) consentaneously mention psychotherapy as the treatment of choice for BPD.”
BackgroundInfluentialPascual, J. C., Córcoles, D., Castano, J., Gines, J. M., Gurrea, A., Martín‐Santos, R., García-Ribera, C., Pérez, V., & Bulbena, A. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.9.1199 · Cited by 71
Management of borderline personality disorder
Biskin, R. S., & Paris, J. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.112055 · Cited by 66
“Partial responses to medications are common, frequently leading to polypharmacy and treatment for longer than may be necessary.(42,50) Trying 1 medication at a time is suggested, even in the context of partial response, because there is no evidence to support polypharmacy.”
BackgroundTreatment Utilization by Gender in Patients With Borderline Personality Disorder
Goodman, M., Patil, U., Steffel, L., Avedon, J., Sasso, S., Triebwasser, J., & Stanley, B. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000375711.47337.27 · Cited by 52
Bozzatello, P., Rocca, P., Rosa, M. L. D., & Bellino, S. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1686482 · Cited by 64
“The high prevalence significantly impacts mental health services [15,16].”
BackgroundPascual, J. C., Martín‐Blanco, A., Soler, J., Ferrer, A., Tiana, T., Álvarez, E., & Pérez, V. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833e23ed · Cited by 49
“…show good efficacy and tolerability in the treatment of BPD or some of its characteristic symptoms [American Psychiatric Association (APA), 2001; Zanarini et al., 2004b; Rinne and Ingenhoven, 2007; National Institute for Clinical Excellence (NICE), 2009; Ingenhoven et al., 2010; Lieb et al.,…”
BackgroundResultInfluentialZimmerman, M., Ward, M., D’Avanzato, C., & Wilner, J. G. (2021) · Journal of Personality Disorders · doi:10.1521/pedi_2021_35_539 · Cited by 51
Riffer, F., Farkas, M., Streibl, L. E., Kaiser, E., & Sprung, M. S. (2019) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2019.1576904 · Cited by 53
“However, in clinical practice the use of long-term treatment with psychotropic medication is very common in patients with BPD, with about 80% of BPD patients taking at least one drug for most of the time during a 6-year period (Zanarini et al., 2004).”
BackgroundPsychological therapies for people with borderline personality disorder
Storebø, O. J., Stoffers-Winterling, J. M., Völlm, B. A., Kongerslev, M. T., Mattivi, J. T., Kielsholm, M. L., Nielsen, S. S., Jørgensen, M. P., Faltinsen, E. G., Lieb, K., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012955 · Cited by 47
Borderline and antisocial personality disorders: summary of NICE guidance
Kendall, T., Pilling, S., Tyrer, P. J., Duggan, C. F., Burbeck, R., Meader, N., Taylor, C. J., & groups, O. B. O. T. G. D. (2009) · BMJ · doi:10.1136/bmj.b93 · Cited by 47
Miller, J. D., Morse, J. Q., Nolf, K. A., Stepp, S. D., & Pilkonis, P. A. (2012) · Journal of Abnormal Psychology · doi:10.1037/a0027410 · Cited by 55
Belli, H. (2012) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1042w · Cited by 58
“However, cases which have not got into even partial remission, may also be observed [39, 40].”
BackgroundComtois, K. A., Kerbrat, A. H., Atkins, D. C., Harned, M. S., & Elwood, L. (2010) · Psychiatric Services · doi:10.1176/appi.ps.61.11.1106 · Cited by 44
Besag, F., Vasey, M. J., Sharma, A., & Lam, I. C. H. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211045870 · Cited by 62
Zanarini, M. C., Frankenburg, F. R., Reich, D. B., Wedig, M. M., Conkey, L. C., & Fitzmaurice, G. M. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12255 · Cited by 43
Self-citationMethodological Considerations for Treatment Trials for Persons with Borderline Personality Disorder
Zanarini, M. C., Stanley, B., Black, D. W., Markowitz, J. C., Goodman, M., Pilkonis, P., Lynch, T. R., Levy, K., Fonagy, P., Bohus, M., et al. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200202 · Cited by 43
“54,55 Many patients take multiple concurrent medications despite the lack of evidence supporting this practice.”
Self-citationKolla, N. J., Mizrahi, R., Karas, K., Wang, C., Bagby, R. M., McMain, S., Simpson, A. I. F., Rusjan, P., Tyndale, R. F., Houle, S., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0731-y · Cited by 66
“Although the mainstay of treatment for BPD is psychotherapy, pharmacological interventions play an important role in managing the disorder, evidenced by the fact that 40% of BPD patients take three or more psychotropic medications concurrently, 20% receive four or more medications, and 10% require greater than five ps…”
BackgroundOxcarbazepine in the Treatment of Bipolar Disorder: A Review
Pratoomsri, W., Yatham, L. N., Bond, D. J., Lam, R. W. M., & Sohn, C. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100809 · Cited by 41
Treatment of Borderline Personality Disorder
Levy, K. N., McMain, S., BATEMAN, A. W., & Clouthier, T. L. (2018) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2018.07.011 · Cited by 56
Borderline Personality Disorder and Mental Healthcare Service Use Among Adolescents
Cailhol, L., Jeannot, M., Rodgers, R., Guelfi, J. D., Perez-Diaz, F., Pham-Scottez, A., Corcos, M., & Speranza, M. (2013) · Journal of Personality Disorders · doi:10.1521/pedi.2013.27.2.252 · Cited by 39
Attachment Theory and Multiple Integrated Treatments of Borderline Patients
Liotti, G., Cortina, M., & Farina, B. (2008) · Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry · doi:10.1521/jaap.2008.36.2.295 · Cited by 45
Sinnaeve, R., van den Bosch, L. M. C., Roijen, L. H., & Vansteelandt, K. (2018) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-018-0089-5 · Cited by 47
Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review
Fineberg, S. K., Gupta, S., & Leavitt, J. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000200 · Cited by 42
Martín‐Blanco, A., Ancochea, A., Soler, J., Elices, M., Carmona, C., & Pascual, J. C. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12767 · Cited by 40
“(12) in 2004 reported that more than 70% of patients with BPD were taking medication.”
BackgroundBipolar II Disorder: An Overview of Recent Developments
Hadjipavlou, G. A., Mok, H., & Yatham, L. N. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901203 · Cited by 38
Personality disorder and public mental health
Tyrer, P. (2008) · Clinical Medicine · doi:10.7861/clinmedicine.8-4-423 · Cited by 35
Carmel, A., Fruzzetti, A. E., & Rose, M. L. (2013) · Community Mental Health Journal · doi:10.1007/s10597-013-9679-2 · Cited by 48
“These individuals are often found to be high utilizers of acute psychiatric services, including inpatient admissions, crisis and emergency services (Bateman and Fonagy 2008; Comtois et al. 2007; Zanarini et al. 2004), and previous A.”
BackgroundBorderline Personality Disorder
Gunderson, J. G., Weinberg, I., & Choi-Kain, L. W. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.2.129 · Cited by 44
Prescribing and borderline personality disorder
Chanen, A. M., & Thompson, K. N. (2016) · Australian Prescriber · doi:10.18773/austprescr.2016.019 · Cited by 34
Metadata
- Authors
- Zanarini, M. C., Frankenburg, F. R., Hennen, J., & Silk, K. R.
- Affiliations
- Harvard University (US)
- ORCID
- Zanarini, Mary C.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2004-01-15
- Volume
- 65
- Issue
- 1
- Pages
- 28-36
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2993584274
- Cited by
- 285
- References
- 0
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 11 · 2021: 14 · 2020: 11 · 2019: 18 · 2018: 21 · 2017: 9 · 2016: 16 · 2015: 10 · 2014: 16 · 2013: 12 · 2012: 17
- FWCI
- 18.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-62169, R29MH047588, R01MH062169, MH-47588)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- borderline personality disorder, mental health service utilization, psychiatric hospitalization, outpatient psychotherapy, polypharmacy, psychotropic drugs, Axis II personality disorders, long-term follow-up, treatment continuity
- MeSH terms
- Adolescent, Adult, Borderline Personality Disorder, Drug Therapy, Female, Hospitalization, Humans, Inpatients, Male, Mental Health Services, Outpatients, Prospective Studies, Psychotherapy, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.